Evidence map›Paper›PMID 40183971›Full record

Observational studyJournal of neurology2025

Delayed neurological recovery in ischemic stroke patients undergoing endovascular treatment is associated with baseline hyperglycemia: a treatable cause of the stunned brain phenomenon?

Susan Klapproth, Lukas Meyer, Helge Kniep, Matthias Bechstein, Anna Kyselyova, Susanne Gellißen, Christian Heitkamp, Laurens Winkelmeier, Uta Hanning, Gerhard Schön and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Susan KlapprothDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. s.klapproth@uke.de.ORCID http://orcid.org/0009-0002-9840-0135
Lukas MeyerDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Helge KniepDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Matthias BechsteinDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Anna KyselyovaDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Susanne GellißenDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Christian HeitkampDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Laurens WinkelmeierDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Uta HanningDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Gerhard SchönInstitute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marlene HeinzeDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Karolin SchulteDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Jens FiehlerDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Gabriel BroocksDepartment of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIn ischemic stroke, there is limited data regarding the impact of baseline hyperglycemia on the treatment effect of recanalization on neurological recovery. This study aimed to directly compare-how short- and long-term serum glucose levels modify the effect of recanalization on functional outcome in patients with ischemic stroke and specifically analyze the occurrence of delayed neurological recovery ("stunned brain phenomenon").

methodsObservational retrospective analysis including patients with anterior circulation ischemic stroke and large vessel occlusion undergoing mechanical thrombectomy following multimodal-CT upon admission. The primary endpoint was delayed neurological recovery, defined as a lack of early neurological improvement (ENI) at 24 h despite achieving functional independence at day 90. Binary ENI was defined as 24 h-NIHSS ≤ 8 points. The treatment effect of recanalization defined as mTICI 2b-3 was determined for patients with high versus low serum blood glucose (BG, cut-off: 140 mg/dl). Inverse-probability weighting analysis (IPW) was used to assess the treatment effect of recanalization according to glucose profiles.

resultsA total of 348 patients were included in the analysis. The treatment effect of recanalization in patients with low BG on the NIHSS at 24 h and binary ENI was  - 3.5 (95%CI  - 5.3 to  - 1.8, p < 0.001) and 22.4% (95%CI 13.1-31.8, p < 0.001). Furthermore, recanalization in patients with low BG was associated with functional independence at day 90 (26.4%, 95%CI 17.1-35.8, p < 0.001). For patients with high BG, recanalization was not associated with a lower NIHSS at 24 h ( - 1.4, 95%CI  - 3.7-0.9, p = 0.24) although significantly being associated with functional independence at day 90 (+ 14.7%, 95%CI 4.5-24.9, p = 0.005). DISCUSSION: Successful vessel recanalization was associated with better functional outcome at day 90 independent of BG profiles; however, acute hyperglycemia was significantly linked to delayed neurological recovery. Hence, hyperglycemia might be a major cause of the stunned brain phenomenon and might consequently serve as a promising target for adjunctive therapy in the treatment of ischemic stroke patients.

Indexed as

Endovascular ProceduresHyperglycemiaIschemic StrokeRecovery of FunctionAgedAged, 80 and overBlood GlucoseFemaleHumansMaleMiddle AgedRetrospective StudiesThrombectomyTreatment OutcomeBlood GlucoseBlood glucose levelsNWUStroke

Identifiers

PMID40183971
PMCPMC11971131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.